We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Suggests Ways to Reduce Residue in Transdermal Patches
Guidance Suggests Ways to Reduce Residue in Transdermal Patches
August 13, 2010
The FDA is asking device- and drugmakers to comment on its suggestions to minimize the amount of residual drug left in transdermal patches.